These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 582148)

  • 41. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies of the pharmacokinetics and bioavailability of a new trimethoprim/sulfamethoxazole preparation in healthy volunteers].
    Hutt V; Klingmann I; Pabst GU; Salama Z; Nieder M; Jaeger H
    Arzneimittelforschung; 1988 Sep; 38(9):1347-50. PubMed ID: 3265624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics of the combined preparation trimezole--Farmakhim. II. Comparative pharmacokinetic studies of trimezole and biseptol in healthy volunteers].
    Mikhaĭlova D; Mikhaĭlova S; Bogoslovova T; Prodanova K; Raĭnova L
    Eksp Med Morfol; 1986; 25(1):13-20. PubMed ID: 3488900
    [No Abstract]   [Full Text] [Related]  

  • 44. Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
    Mylotte JM; Bates TR; Sergeant KA; Matson RE; Beam TR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):81-7. PubMed ID: 7025751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and Safety of Sulfamethoxazole-Trimethoprim After Oral Administration of Single and Multiple Doses to Rhode Island Red Chickens (
    Petritz OA; Enomoto H; Meyer EG; Thomson A; Baynes RE; Flammer K
    J Avian Med Surg; 2023 Jun; 37(1):1-12. PubMed ID: 37358198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The resorption of cotrimoxazol from preparations produced by different manufacturies (author's transl)].
    Windorfer A; Schipper R
    Med Klin; 1979 Jul; 74(28-29):1101-4. PubMed ID: 481308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology of trimethoprim-sulfamethoxazole in newborn infants.
    Springer C; Eyal F; Michel J
    J Pediatr; 1982 Apr; 100(4):647-50. PubMed ID: 7062219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.
    Morgan DJ; Raymond K
    Antimicrob Agents Chemother; 1980 Feb; 17(2):132-7. PubMed ID: 7387137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
    Wright WL; Larking P; Lovell-Smith CJ
    Br J Urol; 1982 Oct; 54(5):550-1. PubMed ID: 6983378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients.
    Naber K; Vergin H; Weigand W
    Infection; 1981; 9(5):239-43. PubMed ID: 6975241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; McFaden K; Jack ML; Weissman L
    J Infect Dis; 1973 Nov; 128():Suppl:547-55 p. PubMed ID: 4758045
    [No Abstract]   [Full Text] [Related]  

  • 52. Data on the pharmacokinetics of sulphamethoxazole and trimethoprim in buffalo calves.
    Jain SK; Uppal RP
    Zentralbl Veterinarmed A; 1984 Feb; 31(1):25-30. PubMed ID: 6426202
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).
    Patel RB; Welling PG
    Clin Pharmacokinet; 1980; 5(5):405-23. PubMed ID: 7408366
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.
    Welling PG; Craig WA; Amidon GL; Kunin CM
    J Infect Dis; 1973 Nov; 128():Suppl:556-66 p. PubMed ID: 4758046
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetics of trimethoprim-sulphamethoxazole in two-day-old foals after a single intravenous injection.
    Brown MP; McCartney JH; Gronwall R; Houston AE
    Equine Vet J; 1990 Jan; 22(1):51-3. PubMed ID: 2298191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacokinetic consequences of the mode of administration of cotrimoxazole in humans].
    Kremers P; Mélon G; Heusghem C
    Rev Med Liege; 1975 Feb; 30(4):103-9. PubMed ID: 1224089
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of pharmacokinetic interaction between glibenclamide and trimethoprim-sulphamethoxazole.
    Sjöberg S; Wiholm BE; Gunnarsson R; Emilsson H; Thunberg E; Christenson I; Ostman J
    Diabet Med; 1987; 4(3):245-7. PubMed ID: 2956028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of oral co-trimazine and the penetration of its components sulfadiazine and trimethoprim into peripheral human lymph.
    Bergan T; Engeset A; Olszewski W
    Chemotherapy; 1986; 32(3):209-21. PubMed ID: 3709270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of sulfamethoxazole and trimethoprim in Mexicans: bioequivalence of two oral formulations (URO-TS D and Bactrim F).
    Flores-Murrieta FJ; Castañeda-Hernández G; Menéndez JC; Chávez F; Herrera JE; Hong E
    Biopharm Drug Dispos; 1990 Dec; 11(9):765-72. PubMed ID: 2271752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-trimoxazole: kinetic differences and the route of administration.
    Lazaro A; Badia A
    J Antimicrob Chemother; 1977 Sep; 3(5):528-9. PubMed ID: 903337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.